These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8991704)

  • 1. [Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia].
    Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Fiziol Zh (1994); 1996; 42(1-2):10-6. PubMed ID: 8991704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cardioprotective action of preparations of biotechnological cytochrome c in acute myocardial ischemia].
    Gatsura VV; Sernov LN; Davidov ER
    Eksp Klin Farmakol; 1998; 61(2):27-9. PubMed ID: 9621169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of fructose-1,6-diphosphate, cytochrome c and their combination on the size of the necrotic area in transient myocardial ischemia].
    Imatdieva RM; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(1):32-4. PubMed ID: 9162279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycerinated myocardiocyte fibers in the rat myocardium as one of the models in a preclinical assessment of antianginal agents].
    Dzhanpoladian EG; Sambelian VM; Kaĭfadzhian MA; Tatinian NG; Khoetsian EL
    Biull Eksp Biol Med; 1989 Apr; 107(4):444-6. PubMed ID: 2720162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased myocardial resistance to ischemia in a chronic model of stenocardia].
    Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Biull Eksp Biol Med; 1993 Sep; 116(9):235-8. PubMed ID: 7509646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of agents used in the therapy of acute ischemic heart disease on the histomorphological changes in the myocardium in acute dystrophy].
    Nikulin AA; Chernov IP
    Farmakol Toksikol; 1979; 42(4):371-6. PubMed ID: 477957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The anti-ischemic properties of new specific bradycardic agents, derivatives of 2-mercaptobenzimidazole].
    Chichkanov GG; Tsorin IB; Kirsanova GIu
    Eksp Klin Farmakol; 1998; 61(6):20-4. PubMed ID: 9929811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The morphological aspects of the anti-ischemic effect of a low-intensity helium-neon laser on the coronary vessels (experimental research)].
    Ruzov VI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1995; (3):27-8. PubMed ID: 7483383
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 12. [The protective effect of 17 beta-estradiol in experimental myocardial infarct].
    Mambetova AZh; Matiushin AI; Shimanovskiĭ NL; Karachentsev AN
    Eksp Klin Farmakol; 1996; 59(2):15-6. PubMed ID: 8974555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of a new phenylalkyl taurine derivative on the size of the necrotic area in experimental myocardial infarct in rats].
    Sapronov NS; Torkunov PA; Eliseev VV; Krylova IB; Evdokimova NR
    Patol Fiziol Eksp Ter; 1999; (4):19-20. PubMed ID: 10598458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.
    Laham RJ; Rezaee M; Post M; Novicki D; Sellke FW; Pearlman JD; Simons M; Hung D
    J Pharmacol Exp Ther; 2000 Feb; 292(2):795-802. PubMed ID: 10640320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transient ischemia as a factor in modelling regulated coronarogenic alteration in the myocardium].
    Gatsura VV; Imatdieva RM
    Eksp Klin Farmakol; 1994; 57(6):63-5. PubMed ID: 7756970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hibernating myocardium: a review.
    Heusch G; Schulz R
    J Mol Cell Cardiol; 1996 Dec; 28(12):2359-72. PubMed ID: 9004153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
    Syroïd DV; Sokrut VM; Shvyrenko IR
    Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: influence of acute ischemia/cardioplegia and reperfusion.
    Wang Y; Gabrielsen A; Lawler PR; Paulsson-Berne G; Steinbrüchel DA; Hansson GK; Kastrup J
    Microcirculation; 2006; 13(3):187-97. PubMed ID: 16627361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade.
    Trescher K; Bauer M; Dietl W; Hallström S; Wick N; Wolfsberger M; Ullrich R; Jürgens G; Wolner E; Podesser BK
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):1005-11, 1011e1. PubMed ID: 19327531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.